ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,999.30
-0.23%
S&P ASX All Technology
3,160.00
-0.16%
Brent Oil
83.075
-1.50%
US Dollar vs AUD
1.483
0.30%
Bitcoin
63,971.03
-1.36%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Nightstar Therapeutics Plc ADS (NITE)

  7. Nightstar Therapeutics Plc ADS (NITE) News

NITE

Nightstar Therapeutics Plc ADS (NITE)

Nightstar Therapeutics Plc ADS
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NITE
DateTimeSourceHeadlineSymbolCompany
13/02/201901:33Edgar (US Regulatory)Schedule 13gNASDAQ:NITENightstar Therapeutics Plc ADS
05/01/201908:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NITENightstar Therapeutics Plc ADS
21/11/201809:07Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NITENightstar Therapeutics Plc ADS
14/11/201800:28Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NITENightstar Therapeutics Plc ADS
14/11/201800:09Edgar (US Regulatory)Schedule 13gNASDAQ:NITENightstar Therapeutics Plc ADS
13/11/201817:00GlobeNewswire Inc.Nightstar Announces Planned Initiation of Phase 2/3 Expansion Study in XIRIUS Trial for NSR-RPGR in XLRP and Reports Third Qu...NASDAQ:NITENightstar Therapeutics Plc ADS
08/11/201822:05GlobeNewswire Inc.Nightstar Therapeutics to Participate in Multiple Conferences in NovemberNASDAQ:NITENightstar Therapeutics Plc ADS
10/10/201800:41Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NITENightstar Therapeutics Plc ADS
04/10/201820:05GlobeNewswire Inc.Nightstar Therapeutics to Present at Chardan Genetic Medicines ConferenceNASDAQ:NITENightstar Therapeutics Plc ADS
03/10/201806:05GlobeNewswire Inc.Nightstar Announces Closing of Public Offering and Full Exercise of Underwriters’ OptionNASDAQ:NITENightstar Therapeutics Plc ADS
01/10/201820:05GlobeNewswire Inc.Nightstar Therapeutics to Present at 2018 Cell & Gene Meeting on the MesaNASDAQ:NITENightstar Therapeutics Plc ADS
29/09/201806:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:NITENightstar Therapeutics Plc ADS
28/09/201820:15Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NITENightstar Therapeutics Plc ADS
28/09/201811:11GlobeNewswire Inc.Nightstar Announces Pricing of Public OfferingNASDAQ:NITENightstar Therapeutics Plc ADS
27/09/201820:08Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:NITENightstar Therapeutics Plc ADS
26/09/201806:25GlobeNewswire Inc.Nightstar Announces Proposed Public Offering of American Depositary SharesNASDAQ:NITENightstar Therapeutics Plc ADS
26/09/201806:22Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:NITENightstar Therapeutics Plc ADS
26/09/201806:11Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NITENightstar Therapeutics Plc ADS
24/09/201822:08Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NITENightstar Therapeutics Plc ADS
23/09/201801:57GlobeNewswire Inc.Nightstar Reports Positive Proof of Concept Data from Dose Escalation Study in XIRIUS Trial for NSR-RPGR in XLRP PatientsNASDAQ:NITENightstar Therapeutics Plc ADS
13/09/201820:16Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NITENightstar Therapeutics Plc ADS
13/09/201820:05GlobeNewswire Inc.Nightstar Appoints Strategic Biotechnology Executive Paula Cobb to its Board of DirectorsNASDAQ:NITENightstar Therapeutics Plc ADS
16/08/201807:33Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NITENightstar Therapeutics Plc ADS
13/08/201822:32Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NITENightstar Therapeutics Plc ADS
13/08/201820:05GlobeNewswire Inc.Nightstar Therapeutics Reports Second Quarter 2018 Financial Results and Business HighlightsNASDAQ:NITENightstar Therapeutics Plc ADS
11/08/201800:01Edgar (US Regulatory)Schedule 13gNASDAQ:NITENightstar Therapeutics Plc ADS
08/08/201807:28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NITENightstar Therapeutics Plc ADS
07/08/201820:05GlobeNewswire Inc.Nightstar Therapeutics to Present at Wedbush PacGrow Healthcare ConferenceNASDAQ:NITENightstar Therapeutics Plc ADS
28/07/201806:13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NITENightstar Therapeutics Plc ADS
14/06/201821:37Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:NITENightstar Therapeutics Plc ADS
 Showing the most relevant articles for your search:NASDAQ:NITE

Your Recent History

COIN
ETHUSD
Ethereum
ASX
FMG
Fortescue
PM
XAUUSD
Gold vs US Dollar
ASX
XFL
S&P ASX 50
ASX
WDC
Westfield
NYSE
MRK
Merck
ASX
CSL
CSL
ASX
ANZ
Australia And New Zealan...
NASDAQ
AMZN
Amazon.com
ASX
WES
Wesfarmers
ASX
MQG
Macquarie
NYSE
KO
Coca Cola
NYSE
XOM
Exxon Mobil
ASX
TLS
Telstra
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved